
Jehanne Souaya Sitton
Examiner (ID: 17461, Phone: (571)272-0752 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1682, 1655 |
| Total Applications | 1479 |
| Issued Applications | 528 |
| Pending Applications | 307 |
| Abandoned Applications | 653 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19389856
[patent_doc_number] => 20240279726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => A METHOD TO AMPLIFY AND DETECT TARGET NUCLEIC ACIDS WITH VERY HIGH SPECIFICITY AND SENSITIVITY
[patent_app_type] => utility
[patent_app_number] => 18/571481
[patent_app_country] => US
[patent_app_date] => 2022-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18571481
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/571481 | A METHOD TO AMPLIFY AND DETECT TARGET NUCLEIC ACIDS WITH VERY HIGH SPECIFICITY AND SENSITIVITY | Jun 17, 2022 | Pending |
Array
(
[id] => 18376340
[patent_doc_number] => 20230151424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => GENETIC MARKERS FOR PREDICTING RESPONSIVENESS TO THERAPY WITH HDL-RAISING OR HDL MIMICKING AGENT
[patent_app_type] => utility
[patent_app_number] => 17/842282
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842282
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/842282 | Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agent | Jun 15, 2022 | Issued |
Array
(
[id] => 19557748
[patent_doc_number] => 20240369540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => MECHANISMS AND PREDICTORS OF ADJUVANTICITY AND ANTIBODY DURABILITY
[patent_app_type] => utility
[patent_app_number] => 18/567325
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18567325
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/567325 | MECHANISMS AND PREDICTORS OF ADJUVANTICITY AND ANTIBODY DURABILITY | Jun 13, 2022 | Pending |
Array
(
[id] => 20657995
[patent_doc_number] => 20260110034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-04-23
[patent_title] => IMPROVED METHODS TO DIAGNOSE HEAD AND NECK CANCER AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/534101
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18534101
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/534101 | IMPROVED METHODS TO DIAGNOSE HEAD AND NECK CANCER AND USES THEREOF | Jun 8, 2022 | Pending |
Array
(
[id] => 19404075
[patent_doc_number] => 20240287586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => PRODUCT AND METHOD FOR ANALYZING OMICS INFORMATION OF SAMPLE
[patent_app_type] => utility
[patent_app_number] => 18/567583
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18567583
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/567583 | PRODUCT AND METHOD FOR ANALYZING OMICS INFORMATION OF SAMPLE | Jun 5, 2022 | Pending |
Array
(
[id] => 18021083
[patent_doc_number] => 20220372582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => TERT PROMOTER MUTATIONS IN CANCER
[patent_app_type] => utility
[patent_app_number] => 17/831814
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831814
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831814 | TERT PROMOTER MUTATIONS IN CANCER | Jun 2, 2022 | Abandoned |
Array
(
[id] => 19738567
[patent_doc_number] => 12215387
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-04
[patent_title] => Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment
[patent_app_type] => utility
[patent_app_number] => 17/829859
[patent_app_country] => US
[patent_app_date] => 2022-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20052
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17829859
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/829859 | Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment | May 31, 2022 | Issued |
Array
(
[id] => 18212065
[patent_doc_number] => 20230058329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => BCR-ABL TRUNCATION MUTATIONS
[patent_app_type] => utility
[patent_app_number] => 17/826818
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826818
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/826818 | BCR-ABL TRUNCATION MUTATIONS | May 26, 2022 | Abandoned |
Array
(
[id] => 19556908
[patent_doc_number] => 20240368700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => CANCER CLASSIFICATION AND PROGNOSIS BASED ON SILENT AND NON-SILENT MUTATIONS
[patent_app_type] => utility
[patent_app_number] => 18/562317
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562317
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/562317 | CANCER CLASSIFICATION AND PROGNOSIS BASED ON SILENT AND NON-SILENT MUTATIONS | May 18, 2022 | Pending |
Array
(
[id] => 18005406
[patent_doc_number] => 20220364172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => METHOD FOR DIAGNOSING AND TREATING SUBJECTS HAVING SINGLE NUCLEOTIDE POLYMORPHISMS IN CHROMOSOME 2, 2:107,510,000-107,540,000 LOCUS
[patent_app_type] => utility
[patent_app_number] => 17/740670
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17740670
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/740670 | Method for diagnosing and treating subjects having single nucleotide polymorphisms in chromosome 2, 2:107,510,000-107,540,000 locus | May 9, 2022 | Issued |
Array
(
[id] => 18036636
[patent_doc_number] => 20220380851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => METHODS AND COMPOSITIONS FOR DIAGNOSING, PROGNOSING, AND TREATING ENDOMETRIOSIS
[patent_app_type] => utility
[patent_app_number] => 17/738499
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738499
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/738499 | METHODS AND COMPOSITIONS FOR DIAGNOSING, PROGNOSING, AND TREATING ENDOMETRIOSIS | May 5, 2022 | Abandoned |
Array
(
[id] => 19318721
[patent_doc_number] => 20240240264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => RAPID MILK SAMPLE PREPARATION METHOD COMPATIBLE WITH MOLECULAR TESTS
[patent_app_type] => utility
[patent_app_number] => 18/557791
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6030
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557791
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/557791 | RAPID MILK SAMPLE PREPARATION METHOD COMPATIBLE WITH MOLECULAR TESTS | Apr 27, 2022 | Pending |
Array
(
[id] => 19281980
[patent_doc_number] => 20240218454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => DIAGNOSTIC TO SUPPORT CLINICAL TRIAL MATCHING AND EXPLORATORY BIOMARKER ANALYSES IN CANCER PATIENTS
[patent_app_type] => utility
[patent_app_number] => 18/556748
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36207
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556748
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/556748 | DIAGNOSTIC TO SUPPORT CLINICAL TRIAL MATCHING AND EXPLORATORY BIOMARKER ANALYSES IN CANCER PATIENTS | Apr 21, 2022 | Pending |
Array
(
[id] => 18140946
[patent_doc_number] => 20230014787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE
[patent_app_type] => utility
[patent_app_number] => 17/659641
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17659641
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/659641 | Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence | Apr 17, 2022 | Issued |
Array
(
[id] => 19249140
[patent_doc_number] => 20240200127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => A METHOD FOR IDENTIFYING LEAD SEQUENCES
[patent_app_type] => utility
[patent_app_number] => 18/285822
[patent_app_country] => US
[patent_app_date] => 2022-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18285822
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/285822 | A METHOD FOR IDENTIFYING LEAD SEQUENCES | Apr 5, 2022 | Pending |
Array
(
[id] => 19923231
[patent_doc_number] => 12297502
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Methods and compositions for detecting and diagnosing diseases and conditions
[patent_app_type] => utility
[patent_app_number] => 17/708909
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14946
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17708909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/708909 | Methods and compositions for detecting and diagnosing diseases and conditions | Mar 29, 2022 | Issued |
Array
(
[id] => 17914728
[patent_doc_number] => 20220317123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => DNAZYMES FOR DETECTING LEGIONELLA PNEUMOPHILA
[patent_app_type] => utility
[patent_app_number] => 17/705000
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705000
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705000 | Dnazymes for detecting | Mar 24, 2022 | Issued |
Array
(
[id] => 19188092
[patent_doc_number] => 20240167005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => MODIFIED SHIGELLA APYRASE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/282415
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282415
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/282415 | MODIFIED SHIGELLA APYRASE AND USES THEREOF | Mar 14, 2022 | Pending |
Array
(
[id] => 19302064
[patent_doc_number] => 20240230641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => Methods of Identifying Active Lupus Nephritis Flare
[patent_app_type] => utility
[patent_app_number] => 18/550008
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18550008
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/550008 | Methods of Identifying Active Lupus Nephritis Flare | Mar 10, 2022 | Pending |
Array
(
[id] => 17867504
[patent_doc_number] => 20220290240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => METHODS AND SYSTEMS FOR PREDICTING ALLERGIC RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/692408
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692408
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/692408 | Methods and systems for predicting allergic response | Mar 10, 2022 | Issued |